Recent advances in carcinoid pathogenesis, diagnosis and management

被引：38
作者：
Ganim, RB
Norton, JA
机构：
[1] Vet Affairs Med Ctr, San Francisco, CA 94121 USA
[2] Univ Calif San Francisco, Dept Surg, San Francisco, CA 94143 USA
[3] Univ Calif Davis, Dept Surg, Oakland, CA USA
来源：
SURGICAL ONCOLOGY-OXFORD | 2000年 / 9卷 / 04期
关键词：
carcinoid; somatostatin receptor scintigraphy; positron emission tomography; serotonin receptor; somatostatin analogue; chromogranin A;
D O I：
10.1016/S0960-7404(01)00007-X
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Carcinoid tumors usually present as diagnostic dilemmas due to obscure or nonspecific symptomatology. Advances in molecular biology are allowing the investigation of molecular markers of aggressiveness, better serum tumor markers, as well as the molecular pathogenesis of carcinoid heart disease. Somatostatin receptor scintigraphy (SRS) and whole body positron emission tomography (PET) are providing much improved sensitivity in localization of both primary and metastatic tumors. Long acting depot somatostatin analogues are combining effectivenesss and ease of use for medical management of carcinoid syndrome. An additional benefit may be tumor growth suppression. Published by Elsevier Science Ltd.
引用
收藏
页码：173 / 179
页数：7
相关论文
共 61 条
[1]   PERCUTANEOUS ULTRASONOGRAPHY-GUIDED CUTTING BIOPSY FROM LIVER METASTASES OF ENDOCRINE GASTROINTESTINAL TUMORS [J].
ANDERSSON, T ;
ERIKSSON, B ;
LINDGREN, PG ;
WILANDER, E ;
OBERG, K .
ANNALS OF SURGERY, 1987, 206 (06) :728-732
[2]  
Bajetta E, 1999, CANCER, V86, P858, DOI 10.1002/(SICI)1097-0142(19990901)86:5<858::AID-CNCR23>3.0.CO
[3]  
2-8
[4]   SECRETION OF A CHROMAFFIN GRANULE PROTEIN CHROMOGRANIN FROM ADRENAL GLAND AFTER SPLANCHNIC STIMULATION [J].
BLASCHKO, H ;
COMLINE, RS ;
SCHNEIDER, FH ;
SILVER, M ;
SMITH, AD .
NATURE, 1967, 215 (5096) :58-+
[5]   Valvular heart disease associated with fenfluramine-phentermine [J].
Connolly, HM ;
Crary, JL ;
McGoon, MD ;
Hensrud, DD ;
Edwards, BS ;
Edwards, WD ;
Schaff, HV .
NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (09) :581-588
[6]  
DAVIES MG, 1990, BRIT J SURG, V77, P10
[7]   GENOME-WIDE SEARCH FOR LOSS OF HETEROZYGOSITY IN TRANSGENIC MOUSE-TUMORS REVEALS CANDIDATE TUMOR-SUPPRESSOR GENES ON CHROMOSOME-9 AND CHROMOSOME-16 [J].
DIETRICH, WF ;
RADANY, EH ;
SMITH, JS ;
BISHOP, JM ;
HANAHAN, D ;
LANDER, ES .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (20) :9451-9455
[8]  
DOLAN JP, 2001, SURG BASIC SCI CLIN
[9]   Evaluation of primary pulmonary carcinoid tumors using FDG PET [J].
Erasmus, JJ ;
McAdams, HP ;
Patz, EF ;
Coleman, RE ;
Ahuja, V ;
Goodman, PC .
AMERICAN JOURNAL OF ROENTGENOLOGY, 1998, 170 (05) :1369-1373
[10]   Summing up 15 years of somatostatin analog therapy in neuroendocrine tumors:: Future outlook [J].
Eriksson, B ;
Öberg, K .
ANNALS OF ONCOLOGY, 1999, 10 :S31-S38
1234567